High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients

Acta Haematologica

Volumn 109, Issue 2, 2003, Pages 64-67

  Várkonyi, Judit ^a,c   Tarkovács, Gábor ^a   Karádi, István ^a   Andrikovics, Hajnalka ^b   Varga, Ferenc ^b   Varga, Fatime ^a   Demeter, Judit ^a   Tordai, Attila ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

^c NONE   (Hungary)

Author keywords

HFE gene mutations; Iron overload; Myelodysplastic syndrome

Indexed keywords

IRON; TRANSFERRIN;

ADULT; AGED; ALLELE; ARTICLE; BLAST TRANSFORMATION; BLOOD TRANSFUSION; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INCIDENCE; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HUNGARY; MALE; MIDDLE AGED; MUTATION; MYELODYSPLASTIC SYNDROMES;

EID: 0037217374     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068487     Document Type: Article

References (15)

1. Bouscary D, De Vos J, Gueasnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M: FAS/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndrome. Leukemia 1997;11:839-845.
2. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo RJ, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClellan E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
3. Tordai A, Klein I, Andrikovics H, Kalmár L, Sarkadi B, Rajczy K, Pénzes M, Sarkadi B, Klein I, Váradi A: High frequency of the haemochromatosis C282Y point mutation can argue against its Celtic origin. J Med Genet 1998;35:878-879.
4. Andrikovics H, Kalmár L, Bors A, Fandl B, Petri I, Kalász L, Tordai A: Genotype screening for hereditary hemochromatosis among voluntary blood donors in Hungary. Blood Cells Mol Dis 2001;27:334-341.
5. Weinberg ED: Iron withholding: A defense against infection and neoplasia. Physiol Rev 1984;64:65-102.
6. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990;186:1-85.
7. Loeb LA, James EA, Waltersdorph AM, Klebanoff SJ: Mutagenesis by autoxidation of iron with isolated DNA. Proc Natl Acad Sci USA 1988;85:3918-3922.
8. Nelson RL, Davis FG, Persky V, Becker E: Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875-879.
9. Cazzola M, Bergamaschi G, Dezza L, Arosio P: Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 1990;75:1903-1919.
10. Yaounang J, Grobois B, Jouanolle AM, Goasguen J, Leblay R: Haemochromatosis Cys282Tyr mutation in pyridoxine-sensitive sideroblastic anaemia. Lancet 1997;349:1475-1476.
11. Grobois B, Bibes B, Jouanolle AM, Jego P, Goasguen J, Jardel H, Leblay R, Yaounang J: Hemochromatosis mutations and idiopathic acquired sideroblastic anemia (IASA). Eur J Intern Med 1999;10(suppl 1):S66.
12. Jackson HA, Carter K, Drake C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M: HFE mutations, iron deficiency and overload in 10500 blood donors. Br J Haematol 2001;114:474-484.
13. Rose C, Quarre MC, Vassilieff D, Dreyfus F: Tolerance to deferiprone (L1) in multitransfused patients with myelodysplastic syndrome (MDS). Preliminary results in 9 patients. Leuk Res 1999;23(suppl 1):S50.
14. Rose C, Preudhomme C, Bauters F, Fenaux P: Modalities and effectiveness of iron chelation by deferoxamine (DFO) in multitransfused patients with low risk myelodysplastic syndrome (MDS). Leuk Res 1999;23(suppl 1):S49.
15. Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS, Bunn HF: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981;304:319-324.